4.7 Article

Anticancer and Antioxidant Activities of the Root Extract of the Carnivorous Pitcher Plant Sarracenia purpurea

Journal

PLANTS-BASEL
Volume 11, Issue 13, Pages -

Publisher

MDPI
DOI: 10.3390/plants11131668

Keywords

carnivorous plant; Sarracenia purpurea; anticancer; 4T1 mammary carcinoma; antioxidation; antibacterial; dihydroorotase; SSB; GC-MS analysis; ionone

Categories

Ask authors/readers for more resources

In this study, the antioxidant and anticancer properties of Sarracenia purpurea extracts from different parts of the plant were investigated. The root extract obtained using acetone showed the highest anticancer activities and antioxidant capacity. The combination of the root extract with the anticancer drug 5-fluorouracil exhibited efficient inhibition of breast cancer cells. The root extract also showed potential as an inhibitor of human dihydroorotase, an enzyme involved in cancer chemotherapy.
The carnivorous pitcher plant Sarracenia purpurea exhibits many ethnobotanical uses, including the treatments of type 2 diabetes and tuberculosis-like symptoms. In this study, we prepared different extracts from the leaves (pitchers), stems, and roots of S. purpurea and investigated their antioxidant and anticancer properties. To evaluate the extraction efficiency, we individually used different solvents, namely methanol, ethanol, acetone, and distilled water, for S. purpurea extract preparations. The root extract of S. purpurea, obtained by 100% acetone (S. purpurea-rootacetone), had the highest anticancer activities, antioxidation capacity (the DPPH activity with IC50 of 89.3 +/- 2.2 mu g/mL), antibacterial activities, total phenolic content (33.4 +/- 0.7 mg GAE/g), and total flavonoid content (107.9 +/- 2.2 mg QUE/g). The most abundant compounds in S. purpurea-root-acetone were identified using gas chromatography-mass spectrometry; 7,8-Dihydro-alpha-ionone was the major compound present in S. purpurea-root-acetone. In addition, the alpha-cytotoxicity of S. purpurea-rootacetone (combined with the clinical anticancer drug 5-fluorouracil (5-FU) on the survival, apoptosis, proliferation, and migration of the 4T1 mammary carcinoma) was examined. The combination of 5-FU with S. purpurea-root-acetone could be highly efficient for anti-4T1 cells. We also found that S. purpurea-root-acetone could inhibit the enzymatic activity of human dihydroorotase (huDHOase), an attractive target for potential anticancer chemotherapy. The sic most abundant compounds in S. purpurea-root-acetone were tested using an in silico analysis via MOE-Dock software for their binding affinities. The top-ranked docking conformations were observed for 7,8-dihydro-cc-ionone and stigmast-5-en-3-ol, suggesting the inhibition potential against huDHOase. Overall, the collective data in this study may indicate the pharmacological potentials of S. purpurea-root-acetone for possible medical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available